Paul Knight analyst KEYBANK

Currently out of the existing stock ratings of Paul Knight, 24 are a HOLD (12.77%), 164 are a BUY (87.23%).

Paul Knight

Work Performance Price Targets & Ratings Chart

Analyst Paul Knight, currently employed at KEYBANK, carries an average stock price target met ratio of 49.97% that have a potential upside of 44.08% achieved within 211 days.

Paul Knight’s has documented 350 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.

Most recent stock forecast was given on WST, West Pharmaceutical Services at 02-Jul-2026.

Wall Street Analyst Paul Knight

Analyst best performing recommendations are on CD (CHINDATA GROUP HOLDINGS LTD).
The best stock recommendation documented was for CYRX (CRYOPORT) at 1/19/2021. The price target of $75 was fulfilled within 3 days with a profit of $10.82 (16.86%) receiving and performance score of 56.2.

Average potential price target upside

A Agilent Technologies AVTR Avantor BRKS Brooks Automation CDMO Avid Bioservices CYRX Cryoport DNAY Codex DNA HBIO Harvard Bioscience TMO Thermo Fisher Scientific VCYT Veracyte BLFS BioLife Solutions CSTL Castle Biosciences CTLT Catalent DHR Danaher MRVI Maravai Lifesciences Holdings  RGEN Repligen STVN Stevanato Group SpA TECH Bio-Techne Corp OCX OncoCyte Corp WST West Pharmaceutical Services XGN Exagen AZTA Azenta PKI PerkinElmer LAB Standard Biotools RVTY Revvity FLDM Fluidigm WAT Waters TKNO Alpha Teknova MLAB Mesa Laboratories AA Alcoa Corp BR Broadridge Financial Solutions CD Chindata Group Holdings Ltd IDXG Interpace Biosciences RPID Rapid Micro Biosystems TT Trane Technologies plc

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Jul-2026

$135

$-3.57 (-2.58%)

$180

21 days ago
(09-Jul-2026)

8/10 (80%)

$1.41 (1.06%)

237

Buy Since 06-Apr-2026

$148

$9.43 (6.81%)

$140

24 days ago
(06-Jul-2026)

7/10 (70%)

$17.4 (13.32%)

27

Buy Since 26-Feb-2026

$150

$13.99 (10.29%)

$145

1 months 6 days ago
(24-Jun-2026)

16/22 (72.73%)

$18.37 (13.96%)

122

Buy Since 02-Jun-2026

$155

$18.99 (13.96%)

$145

1 months 28 days ago
(02-Jun-2026)

9/13 (69.23%)

$19.95 (14.77%)

164

Buy Since 24-May-2023

$155

$18.99 (13.96%)

$165

2 months 2 days ago
(28-May-2026)

15/20 (75%)

$19.62 (14.49%)

249

Show more analysts

Please expand the browser size to see the chart

Which stock is Paul Knight is most bullish on?

Potential upside of $61.8 has been obtained for WST (WEST PHARMACEUTICAL SERVICES)

Which stock is Paul Knight is most reserved on?

Potential downside of $1.63 has been obtained for CYRX (CRYOPORT)

What Year was the first public recommendation made by Paul Knight?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?